Remimazolam - Can it become a cost-effective alternative to propofol for intravenous anesthesia and sedation?
Author:
- 16 November 2022
- journal article
- editorial
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 84, 110977
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trialJournal of Anesthesia, 2020
- Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During BronchoscopyChest, 2019
- Is the introduction of new anesthetic drugs and techniques economically justified?Current Opinion in Anaesthesiology, 1997
- Propofol Infusion During Regional AnesthesiaAnesthesia & Analgesia, 1994
- Sedative infusions during local and regional anesthesia: a comparison of midazolarn and propofolJournal of Clinical Anesthesia, 1991
- Pharmacokinetics and Pharmacodynamics of Propofol Infusions during General AnesthesiaAnesthesiology, 1988
- Propofol-Nitrous Oxide Versus Thiopental-isoflurane-nitrous Oxide for General AnesthesiaAnesthesiology, 1988
- Etomidate Inhibits Adrenocortical Function in Surgical PatientsAnesthesiology, 1984
- Inhibition of Adrenal Steroidogenesis by the Anesthetic EtomidateNew England Journal of Medicine, 1984
- Comparative Evaluation of Intravenous Agents for Rapid Sequence Induction—Thiopental, Ketamine, and MidazolamAnesthesiology, 1982